NasdaqGM:SIGAPharmaceuticals
Assessing SIGA Technologies (SIGA) Valuation As Biodefense Strength Draws Renewed Investor Attention
Why SIGA is back on investors’ radar
SIGA Technologies (SIGA) is drawing fresh attention after recent coverage highlighted its TPOXX smallpox antiviral, consistent profitability, and solid balance sheet, even as major new contract or regulatory announcements remain quiet.
See our latest analysis for SIGA Technologies.
At a share price of US$6.77, SIGA has seen a 10.8% 7 day share price return and an 8.3% 30 day share price return, while its 1 year total shareholder return of 19.1% points to...